|
ATL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.160510E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.200000E-04 |
| Normal-vs-Stage2 |
1.725190E-01 |
| Normal-vs-Stage3 |
5.175900E-04 |
| Normal-vs-Stage4 |
1.09929999547731E-08 |
| Stage1-vs-Stage2 |
2.824000E-01 |
| Stage1-vs-Stage3 |
7.626200E-01 |
| Stage1-vs-Stage4 |
1.243080E-03 |
| Stage2-vs-Stage3 |
2.458600E-01 |
| Stage2-vs-Stage4 |
5.616200E-03 |
| Stage3-vs-Stage4 |
1.088120E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.86060000000921E-05 |
| Normal-vs-AfricanAmerican |
2.720900E-03 |
| Normal-vs-Asian |
2.177400E-04 |
| Caucasian-vs-AfricanAmerican |
6.028000E-01 |
| Caucasian-vs-Asian |
4.951800E-01 |
| AfricanAmerican-vs-Asian |
9.080400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16809999999956E-05 |
| Normal-vs-Female |
2.575600E-04 |
| Male-vs-Female |
2.631600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.821000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.765190E-04 |
| Normal-vs-Age(61-80Yrs) |
2.45419999999053E-05 |
| Normal-vs-Age(81-100Yrs) |
3.243300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.648600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.153900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.011000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.403800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.460000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.141200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.049600E-01 |
| Classical-VS-Follicular |
5.644100E-02 |
| Classical-VS-Other |
5.860800E-01 |
| Classical-VS-Normal |
9.434400E-04 |
| Tall-VS-Follicular |
7.627200E-01 |
| Tall-VS-Other |
4.147000E-01 |
| Tall-VS-Normal |
1.697380E-03 |
| Follicular-VS-Other |
1.865400E-01 |
| Follicular-VS-Normal |
3.70760000000248E-05 |
| Other-VS-Normal |
8.064600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.38679999999825E-05 |
| Normal-vs-N1 |
1.6877099999979E-05 |
| N0-vs-N1 |
3.556200E-01 |
|
|
